[Severe combined immunodeficiency diseases].
Tsuchiya
Shigeru
S
Department of Pediatric Oncology, Institute of Development, Aging and Cancer, Tohoku University.
D000243:Adenosine Deaminase / Q000172:deficiency; D016026:Bone Marrow Transplantation; D004268:DNA-Binding Proteins; D004720:Endonucleases; D015321:Gene Rearrangement; D015316:Genetic Therapy; D018380:Hematopoietic Stem Cell Transplantation; D018398:Homeodomain Proteins; D006801:Humans; D017493:Leukocyte Common Antigens; D009687:Nuclear Proteins; D018121:Receptors, Cytokine / Q000235:genetics; D016511:Severe Combined Immunodeficiency / Q000145:classification / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D045567:VDJ Recombinases
D004268:DNA-Binding Proteins; D018398:Homeodomain Proteins; D009687:Nuclear Proteins; C499311:RAG2 protein, human; D018121:Receptors, Cytokine; C064655:V(D)J recombination activating protein 2; C064658:RAG-1 protein; D045567:VDJ Recombinases; C426344:DCLRE1C protein, human; D004720:Endonucleases; D017493:Leukocyte Common Antigens; D000243:Adenosine Deaminase